A Phase 3 Study of Tanezumab for Chronic Low Back Pain
Clinical trial NCT02528253 · COMPLETED
Trial details
- NCT number
- NCT02528253
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-18
- Primary completion
- 2017-10-17
- Enrollment
- 1832
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.